Search again:
…The World Health Organization (WHO) recommends daily use of the antibiotic co-trimoxazole (CTX) to prevent infections in HIV-infected children. In addition to reducing deaths from infections, CTX also improves growth,…
Anticancer peptides (ACPs) are small peptides (short chains of amino acids) that kill cancer cells by puncturing them or by triggering programmed cell suicide. In the lab, certain ACPs kill…
…kind of antibodies (IgE) is associated with allergic asthma development in humans, and treating mice with antibiotics results in high levels of IgE. We will test whether changing IgE levels…
Tuberculosis (TB) and non-tuberculous mycobacterial infections (NTMs) are bacterial infections that create serious problems in BC. Treating TB costs the health system nearly $13 million per year, and NTMs are…
…use the most relevant experiences to develop the PEIRS; then, evaluate the validity and reliability of PEIRS. We will used a mixed qualitative and quantitative study design. First, a secondary…
…applicable to the human nervous system and to diseases associated with nervous system defects. Using C. elegans, Dr. Mizumoto will explore how neurons communicate with their neighboring neurons/cells to…
…no way to promote the beneficial actions of SIGIRR in the gut. Recently, however, a newly recognized anti-inflammatory compound called interleukin (IL)-37 has been shown to interact with SIGIRR to…
…a similar threshold in all patients; however, its efficacy in improving neurological outcomes has not been consistent, and in some patients has been found to actually worsen outcomes. A more…
…neither his [family] doctor nor his pharmacist were aware of what had happened.” Hospital pharmacist, 2012 Using combined professional and research expertise we will pilot-test, refine, implement and evaluate ActionADE,…
…a metastatic disease state. Dr. Williams’ research aims to address these issues by identifying aggressive disease early and uncovering key regulators of metastasis for inhibitor development. Cancer cells are constantly…